Sign In
Buy EQ
$3.11
+0.320 (+11.47%)
At Close: Jun 03, 2026
With Biotech Stocks, Investors Love the Thrill of the Chase
09:30am, Wednesday, 05'th Aug 2020
Individual investors are placing their bets on biotech companies pursuing coronavirus advances. Some invest for fun and profit, while others want to be a part of a historic breakthrough.
Equillium to Present at BTIG Virtual Biotechnology Conference 2020
08:07pm, Thursday, 30'th Jul 2020
LA JOLLA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to tre
Southern California Bancorp Announces Results for the Second Quarter 2020
12:00am, Monday, 27'th Jul 2020
Southern California Bancorp (the “Company”) (OTC Pink: BCAL), the holding company for Bank of Southern California, N.A. (the “Bank”) today reported re
Zacks: Analysts Anticipate Equillium (NYSE:EQ) to Announce -$0.44 Earnings Per Share
02:44pm, Thursday, 16'th Jul 2020
Wall Street analysts expect Equillium (NYSE:EQ) to announce ($0.44) earnings per share for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Equilliu
20 Healthcare Stocks Moving In Thursday's Pre-Market Session
12:00am, Thursday, 16'th Jul 2020
Gainers
• AC Immune, Inc. (NASDAQ:ACIU) shares rose 88.45% to $13.55 during Thursday's pre-market session.
• Nabriva Therapeutics, Inc. (NASDAQ:NBRV) stock increased...
Equillium COVID-19 Data, And Other News: The Good, Bad And Ugly Of Biopharma
11:49am, Wednesday, 15'th Jul 2020
Equillium reports positive data for COVID-19 drug trial. CytoDyn's BLA filing is rejected.
Artelo Biosciences Reports Q3 Results, Talks Patent For Cocrystal CBD
12:00am, Wednesday, 15'th Jul 2020
Artelo Biosciences (NASDAQ: ARTL) announced its third-quarter results as of May 31.
The La Jolla, California-based company reported a net loss of $951,191,...
Equillium (EQ) Stock Price Target Gets a Big Boost; Here’s What You Need to Know
03:47pm, Tuesday, 14'th Jul 2020
Headline grabbing biotechs are far from a rare sight in 2020. Nevertheless, when a little-known micro-cap pops by 730% in a single trading session, avid market followers are likely to take notice.And
Equillium Gains From Positive Results on Coronavirus Drug
02:54pm, Tuesday, 14'th Jul 2020
Equillium (EQ) soars on positive results on pipeline candidate, itolizumab, for COVID-19.
EQUILLIUM : CLINICAL TRIAL SHOWS ITOLIZUMAB REDUCES MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19 | MarketScreener
12:22pm, Tuesday, 14'th Jul 2020Vaccine Makers BioNTech, Moderna, And Novavax Set To Run Higher
12:00am, Tuesday, 14'th Jul 2020
Stocks Analysis by Harry Boxer covering: KB Home, Vaxart Inc, Novavax Inc, Altimmune Inc. Read Harry Boxer's latest article on Investing.com
Equillium Explodes 260% On Positive Covid-19 Results; India Approval
11:33am, Monday, 13'th Jul 2020
Shares in biotech Equillium (EQ) have almost tripled in Monday’s pre-market trading after the company announced that a clinical trial conducted in India by its partner Biocon demonstrated that ito
Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19
07:30am, Monday, 13'th Jul 2020
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from.
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.04%
12:00am, Monday, 13'th Jul 2020
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.04%
-$0.43 Earnings Per Share Expected for Equillium (NYSE:EQ) This Quarter
06:14am, Wednesday, 24'th Jun 2020
Analysts expect Equillium (NYSE:EQ) to post earnings per share (EPS) of ($0.43) for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Equillium’s ear
